Laurion Capital Management LP 4 D Molecular Therapeutics, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$9.76 - $21.25 $515,601 - $1.12 Million	52,828 New	52,828 $1.07 Million
Q4 2022 Feb 14, 2023	SELL	$6.85 - $25.46 $1.53 Million - $5.7 Million	-223,722 Reduced 91.27%	21,401 $475,000
Q4 2021 Feb 14, 2022	SELL	$19.56 - $32.94 $586,800 - $988,199	-30,000 Reduced 10.9%	245,123 $5.38 Million
Q2 2021 Aug 13, 2021	SELL	$22.2 - $42.29 $25,996 - $49,521	-1,171 Reduced 0.42%	275,123 $6.63 Million
Q1 2021 May 14, 2021	BUY	$35.94 - $52.67 $7.85 Million - $11.5 Million	218,294 Added 376.37%	276,294 $12 Million

Q4 2020 Feb 12, 2021	BUY	$38.43 - $47.36 $2.23 Million - $2.75 Million	58,000 New	58,000 $2.4 Million

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $675M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.